Insider Holders & Insider Ownership - Histogen Inc. (HSTO)

List of insiders holdings for Histogen Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
ADVENT VENTURE PARTNERS LLP
10% Owner
2014-02-13 14:01:022,243,503
0
2,243,503Form 13G
Perret Marc Olivier
Director
10% Owner
2013-08-01 19:18:1030,000
1,504,062
1,534,062Form 4
COOPERATIVE GILDE HEALTHCARE II U.A.
10% Owner
2013-08-01 19:10:351,504,062
0
1,504,062Form 4
KLINGENSTEIN PAUL H
Director
2014-02-25 17:37:5840,644
1,404,535
1,445,179Form 4
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
KAILIAN VAUGHN M
Vander Vort John
10% Owner
2013-08-01 14:19:530
1,241,016
1,241,016Form 4
Mento Steven J
President and CEO
2023-03-14 16:32:12213,587
0
213,587Form 4
Hagerty David T
EVP, Clinical Development
2019-02-11 16:15:20175,000
0
175,000Form 4
Latterich Martin
SVP, Technical Operations
2022-02-22 18:18:41134,900
0
134,900Form 4
RIPLEY DANIEL L.
SVP, Bus Dev, P&A Mgmt
2019-02-11 16:19:31100,000
32,431
132,431Form 4
Smith Edward F III
SVP, Reg Affairs and QA
2019-02-11 16:20:30110,875
0
110,875Form 4
Knudson Susan A.
COO and CFO
2023-03-14 16:33:04106,793
0
106,793Form 4
Spada Alfred P.
See Remarks
2023-02-27 16:18:17106,793
0
106,793Form 4
Daniels Moya
See Remarks
2021-01-15 16:11:52100,000
0
100,000Form 4
Naughton Gail K
See Remarks
2021-01-15 16:14:2395,000
0
95,000Form 4
VANDERTIE MICHELLE L
Vice President, Finance
2019-08-01 16:13:4486,375
0
86,375Form 4
Reyes Joyce
See Remarks
2023-04-28 18:56:2664,076
0
64,076Form 4/A
Cashion Charles
SVP, Finance, CFO and Sec.
2017-02-01 16:21:3357,500
0
57,500Form 4
BURGESS GARY C.
Sr. VP, Clin. Res. & CMO
2014-02-11 16:49:5150,000
0
50,000Form 4
HALE DAVID F
Director
2019-07-01 16:31:0145,000
0
45,000Form 4
Pascoe Richard W
President, CEO & Director
2021-03-30 18:28:0130,000
0
30,000Form 4
Scott Kathleen D.
Director
2019-11-19 16:10:5030,000
0
30,000Form 4
Klassen Preston
Director
2019-07-01 16:33:3620,000
0
20,000Form 4
Malik Shahzad
Director
10% Owner
2016-06-27 16:23:4020,000
0
20,000Form 4
Zhang Yizhuo
Director
2020-10-09 16:15:5720,000
0
20,000Form 4
Chang Stephen
Director
2020-10-09 16:05:3320,000
0
20,000Form 4
Scopa James Paul
Director
2018-06-25 16:07:4120,000
0
20,000Form 4
Van Wart Harold
Director
2019-07-01 16:34:4820,000
0
20,000Form 4
LARUE WILLIAM R
Director
2019-07-01 16:34:1320,000
0
20,000Form 4
Marshall Keith W
EVP, COO & CFO
2020-05-27 06:09:2319,885
0
19,885Form 4
LACASSE LOUIS P
Director
2015-06-15 16:09:3415,000
0
15,000Form 4
Crean David Hugh
Director
2023-06-21 16:07:296835
0
6835Form 4
Fuhrmann Rochelle
Director
2023-06-21 16:08:046835
0
6835Form 4
Jackson Jonathan
Director
2023-06-21 16:08:396835
0
6835Form 4
KISNER DANIEL L
Director
2023-06-21 16:09:196835
0
6835Form 4
Satz Brian
Director
2023-06-21 16:10:026835
0
6835Form 4
Windham-Bannister Susan Richards
Director
2023-06-21 16:11:056835
0
6835Form 4
Aberdare GP III L.L.C.
Aberdare Ventures III LP
Aberdare Partners III LP
Former 10% Owner
2017-02-13 06:05:325251
0
5251Form 13G
MPM BioVentures IV QP LP
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BIOVENTURES V GP LLC
MPM BIOVENTURES V LLC
MPM BIOVENTURES V L.P.
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
10% Owner
2020-02-05 14:11:030
0
0Form 13G